Introduction {#sec1}
============

Colorectal cancers are among the most common malignant disorders of the gastrointestinal tract. They rank third among cancers causing most deaths in the United States of America \[[@cit0001], [@cit0002]\]. Although a significant proportion of colorectal cancer cases emerge sporadically after the fifth decade of life, some cases are associated with hereditary syndromes or familial colorectal cancer, manifesting early in life. Risk factors for colorectal cancer include lifestyle, age, heredity, polyps, and gene mutations \[[@cit0002]\]. Many factors are possibly related to colorectal cancer mortality, morbidity, and prognosis. The most important patient-related risk factors for colorectal cancer are age, high ASA score, anemia, and low albumin level. The most important disease-related risk factors are tumor stage, histopathological properties (grade, lymph node involvement, lymphovascular invasion), tumor's relationship with adjacent tissues, positivity of surgical borders, treatment approach (surgery, neoadjuvant chemoradiotherapy, adjuvant chemoradiotherapy), and urgency of surgery (elective/emergency). These parameters have been ascribed varying levels of importance by different studies.

Aim {#sec2}
===

Herein, we aimed to investigate various possible demographic, clinical, biochemical, and histopathological parameters as risk factors for mortality among patients undergoing colorectal surgery.

Material and methods {#sec3}
====================

Study design and definitions {#sec3.1}
----------------------------

We retrospectively reviewed the medical records of patients who presented to Kahramanmaras Sutcu Imam University Medical Faculty, General Surgery Clinic or Emergency Department with signs and symptoms of colorectal disease and who subsequently underwent colorectal surgery between January 2008 and November 2015. This study was approved by Sutcu Imam University Faculty of Medicine, Institutional Review Board (Ethics Committee Approval No: 2016-02-08). A total of 101 patients with a histopathologically proven diagnosis of colorectal cancer met the inclusion criteria and were included in the study. Various parameters including age (years), sex (male/female), urgency of admission (elective/emergency), presenting complaint (bleeding/pain/anemia/weight loss/constipation/intestinal obstruction/diarrhea etc.), tumor location (caecum/ascending colon/transverse colon/descending colon/sigmoid colon/rectum), surgical procedure (right hemicolectomy/left colectomy/anterior resection/low anterior resection/total abdominal colectomy/abdominoperineal resection), surgical approach (open/laparoscopic), histopathologic features (adenocarcinoma/mucinous carcinoma/rare types of colorectal cancer), tumor differentiation (well/moderately/poorly), perineural invasion (yes/no), lymphovascular invasion (yes/no), positive lymph node (N+), positive lymph node/total lymph node (N(+)/total N), tumor size (mm), TNM stage, presence of metastasis or locoregional recurrence (yes/no), neoadjuvant chemotherapy (yes/no), neoadjuvant radiotherapy (yes/no), adjuvant radiotherapy (yes/no), adjuvant chemotherapy (yes/no), preoperative and postoperative blood carcinoembryonic antigen (CEA)/CA 19-9 levels, preoperative blood parameters (hemoglobin, thrombocyte count, WBC, neutrophil %, lymphocyte %, lymphocyte/neutrophil %, red cell distribution width (RDW), platelet distribution width (PDW)), duration of hospital stay (days), and follow-up and mortality status were recorded by two researchers (AE, MS).

The metastatic status of the disease was assessed on the basis of the findings of preoperative or postoperative computed tomography, intraoperative exploration, and colonoscopic examination. The presence of locoregional recurrences was assessed with postoperative colonoscopic examination and radiological modalities (computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography computed tomography (PET CT)). This study included patients with follow-up data that spanned at least 3 months. Therefore, patients operated on in November 2015 at the latest were included in the study. The survival status of the patients was determined using the National Death Certificate System. The follow-up duration was determined as the time between surgery and the latest outpatient clinic visit in the surviving patients and the time between surgery and death in the deceased ones. The disease-free survival was determined as the time between surgery and the detection of the first recurrence.

Primary endpoints {#sec3.2}
-----------------

The primary objective of the present study was to determine the risk factors for mortality after colorectal surgery. To achieve that goal, the patients were assigned to two groups named as the surviving (*n* = 76) and deceased (*n* = 25) groups. The groups were compared with respect to study parameters. The independent predictors of mortality were also determined.

Statistical analysis {#sec3.3}
--------------------

The statistical analyses were carried out using SPSS 22.0 (IBM Corporation, Armonk, New York, United States), PAST 3 (Hammer, Ø., Harper, D.A.T., Ryan, P.D. 2001. Paleontological statistics), and MedCalc 14 (Acacialaan 22, B-8400 Ostend, Belgium) software packages. The normality of the distribution of the single and multiple variables was tested using the Shapiro-Wilk test and the Mardia (Dornik and Hansen omnibus) tests, respectively, and the homogeneity of variances was tested using Levene's test. Continuous variables in the two independent groups were compared using the independent-samples T test with bootstrap samples and the Mann-Whitney U test with the Monte Carlo simulation technique. Paired data were compared with the Wilcoxon signed ranks test with Monte Carlo simulation. Categorical variables (presentation, tumor location, surgery type, pathology, metastasis status, radiochemotherapy usage) were analyzed with the Pearson χ^2^ and Fisher's exact tests with the Monte Carlo simulation technique. Odds ratios with confidence intervals were used to determine the most significant risk factor among statistically significant categorical risk factors. The Kaplan-Meier (product limit method) log rank (Mantel-Cox) method was used to determine the effects of the risk factors on mortality and survival; the Kaplan-Meier (product limit method) method was used to determine the effects of the statistically significant parameters on mortality and survival in a model. The variable-based cut-off value for the mortality was analyzed by a receiver operating characteristics (ROC) curve and the sensitivity and specificity values were calculated. The quantitative variables were expressed as mean ± standard deviation (SD), and median (range) (maximum-minimum). The categorical variables were presented as n (number) and percentage (%). All data were reported with a confidence interval (CI) of 95%, and a p-value of less than 0.05 was considered statistically significant for all statistical analyses.

Results {#sec4}
=======

This study included 101 patients aged 29 and 87 years (mean ± SD: 61.6 ±14.6), of whom 59 were male and 42 were female. The initial admission symptom was rectal bleeding in 23 patients, constipation in 22, obstructive complaints of varying intensity in 22, abdominal pain in 22, anemia in 6, weight loss in 4, diarrhea in 1, and perianal abscess in 1. Seventy-four patients presented to the general surgery clinic while the remainder presented to the emergency department. Twenty-five (24.8%) patients died at postoperative follow-up and 76 (75.2%) patients survived. Detailed demographic, clinical, and histopathological properties of both groups are presented in [Tables I](#t0001){ref-type="table"}--[V](#t0005){ref-type="table"}.

###### 

Comparison of the surviving and deceased groups for the categorical variables

  Outcome                                           Surviving *n* (%)   Deceased *n* (%)   Total *n* (%)   Odds ratio (95% CI)   *P*-value
  --------------------------- --------------------- ------------------- ------------------ --------------- --------------------- -----------
  Sex                         Female                29 (38.2)           13 (52.0)          42 (41.6)                             0.249
  Male                        47 (61.8)             12 (48.0)           59 (58.4)                                                
  Initial presentation        Elective              60 (78.9)           14 (56.0)          74 (73.3)       2.9 (1.1--7.7)        0.036
  Emergency                   16 (21.1)             11 (44.0)           27 (26.7)                                                
  Tumor location              Ascending colon       11 (14.5)           6 (24.0)           17 (16.8)                             0.289
  Caecum                      14 (18.4)             1 (4.0)             15 (14.9)                                                
  Rectum                      27 (35.5)             7 (28.0)            34 (33.7)                                                
  Sigmoid                     19 (25.0)             8 (32.0)            27 (26.7)                                                
  Transverse                  5 (6.6)               3 (12.0)            8 (7.9)                                                  
  Surgery                     Anterior resection    17 (22.4)           5 (20.0)           22 (21.8)                             0.535
  Left hemicolectomy          2 (2.6)               3 (12.0)            5 (5.0)                                                  
  Low anterior                19 (25.0)             6 (24.0)            25 (24.8)                                                
  Miles procedure             5 (6.6)               1 (4.0)             6 (5.9)                                                  
  Right hemicolectomy         27 (35.5)             7 (28.0)            34 (33.7)                                                
  Total colectomy             6 (7.9)               3 (12.0)            9 (8.9)                                                  
  Surgery type                Open                  67 (88.2)           25 (100.0)         92 (91.1)                             0.108
  Laparoscopic                9 (11.8)              0 (0.0)             9 (8.9)                                                  
  Pathology                   Adenocarcinoma        56 (73.7)           23 (92.0)          79 (78.2)                             0.107
  Mucinous carcinoma          12 (15.8)             2 (8.0)             14 (13.9)                                                
  Other                       8 (10.5)              0 (0.0)             8 (7.9)                                                  
  Metastasis                  No                    66 (88.0)           18 (72.0)          84 (84.0)                             0.111
  Yes                         9 (12.0)              7 (28.0)            16 (16.0)                                                
  Perineural invasion         No                    45 (66.2)           11 (44.0)          56 (60.2)                             0.06
  Yes                         23 (33.8)             14 (56.0)           37 (39.8)                                                
  Lymphovascular invasion     No                    48 (70.6)           11 (44.0)          59 (63.4)       3.1 (1.1--7.9)        0.028
  Yes                         20 (29.4)             14 (56.0)           34 (36.6)                                                
  Differentiation             Well differentiated   31 (53.4)           9 (40.9)           40 (50.0)                             0.441
  Moderately differentiated   22 (37.9)             12 (54.5)           34 (42.5)                                                
  Poorly differentiated       5 (8.6)               1 (4.5)             6 (7.5)                                                  
  Neoadjuvant RT              No                    59 (81.9)           21 (95.5)          80 (85.1)                             0.176
  Yes                         13 (18.1)             1 (4.5)             14 (14.9)                                                
  Neoadjuvant CT              No                    59 (81.9)           21 (95.5)          80 (85.1)                             0.176
  Yes                         13 (18.1)             1 (4.5)             14 (14.9)                                                
  Adjuvant RT                 No                    46 (86.8)           13 (81.3)          59 (85.5)                             0.687
  Yes                         7 (13.2)              3 (18.8)            10 (14.5)                                                
  Adjuvant CT                 No                    23 (41.1)           9 (52.9)           32 (43.8)                             0.416
  Yes                         33 (58.9)             8 (47.1)            41 (56.2)                                                

###### 

Comparison of the surviving and deceased groups for continuous (quantitative) variables

  Outcome                   Surviving             Deceased             Total                *P*-value
  ------------------------- --------------------- -------------------- -------------------- -----------
  Age                       58.57 ±14.33          70.96 ±11.39         61.63 ±14.63         0.001
  Hb                        12.38 ±2.23           10.59 ±1.73          11.97 ±2.25          0.001
  Neutrophils (%)           68.22 ±10.43          71.77 ±12.39         69.03 ±10.95         0.201
  Lymphocytes/neutrophils   0.36 ±0.20            0.29 ±0.22           0.35 ±0.20           0.166
  Lymphocytes (%)           23 (82--5)            17 (42--4)           22 (82--4)           0.086
  Hospital stay \[days\]    8 (29--3)             7 (29--3)            8 (29--3)            0.862
  Tumor size \[mm\]         40 (190--4)           55 (110--25)         45 (190--4)          0.203
  T stage                   3 (4--0)              3 (4--0)             3 (4--0)             0.058
  N (total)                 12 (72--1)            18 (45--4)           14.5 (72--1)         0.159
  N(+)                      0 (13--0)             1 (44--0)            0 (44--0)            0.009
  N(+)/total N              0 (0.75--0)           0.08 (0.98--0)       0 (0.98--0)          0.012
  Thrombocytes (× 10^3^)    290 (968--144.7)      345.85 (607--71)     298.8 (968--71)      0.047
  WBC                       8305 (18670--3480)    9570 (16760--4520)   8330 (18670--3480)   0.299
  RDW%                      16 (33--4)            17 (23--13)          16 (33--4)           0.073
  PDW                       43.45 (71.7--16.05)   44.4 (56.8--15.82)   43.9 (71.7--15.82)   0.988

###### 

Calculation of the cut-off levels of the statistically significant continuous parameters in [Table II](#t0002){ref-type="table"} using the ROC curve analysis

  Parameter                            Outcome                                  AUC ± SE    Odds ratio (95% CI)   *P*-value[^a^](#tf3-3){ref-type="fn"}   
  ------------------------ ----------- ---------------------------------------- ----------- --------------------- --------------------------------------- ----------
  Age                      ≤ 63        44 (57.9)[\*\*](#tf3-2){ref-type="fn"}   4 (16)      0.759 ±0.055          7.7 (2.1--28.8)                         \< 0.001
  \> 63                    32 (42.1)   21 (84)[\*](#tf3-1){ref-type="fn"}                                                                                 
  Hb                       \> 12.8     30 (40.5)[\*\*](#tf3-2){ref-type="fn"}   1 (4.5)     0.721 ±0.057          13.9 (1.7--109.6)                       \< 0.001
  ≤ 12.8                   44 (59.5)   21 (95.5)[\*](#tf3-1){ref-type="fn"}                                                                               
  N(+)                     ≤ 3         68 (93.2)[\*\*](#tf3-2){ref-type="fn"}   15 (65.2)   0.656 ±0.069          7.1 (1.9--25.8)                         0.025
  \> 3                     5 (6.8)     8 (34.8)[\*](#tf3-1){ref-type="fn"}                                                                                
  N(+)/total N             ≤ 0.0435    53 (72.6)[\*\*](#tf3-2){ref-type="fn"}   9 (39.1)    0.655 ±0.069          3.8 (1.4--10.7)                         0.024
  \> 0.0435                20 (27.4)   14 (60.9)[\*](#tf3-1){ref-type="fn"}                                                                               
  Thrombocytes (× 10^3^)   ≤ 308       44 (59.5)[\*\*](#tf3-2){ref-type="fn"}   7 (31.8)    0.637 ±0.072          3.1 (1.1--8.6)                          0.059
  \> 308                   30 (40.5)   15 (68.2)[\*](#tf3-1){ref-type="fn"}                                                                               

ROC (receiver operating curve) analysis (Youden index J), AUC -- area under the ROC curve, SE -- standard error, CI -- confidence interval.

Sensitivity

specificity

p-value for cut off value.

###### 

Comparison of the surviving and deceased groups for preoperative and postoperative CEA/CA 19--9 levels

  Outcome               Surviving Median (max.--min.)   Deceased Median (max.--min.)   Total Median (max.--min.)   *P*-value
  --------------------- ------------------------------- ------------------------------ --------------------------- -----------
  CEA:                                                                                                             
   Preop = I            2.31 (152--0)                   4.37 (100--1.0)                2.52 (152--0)               0.167
   Postop = II          1.34 (67.9--0)                  6.16 (63.5--0.4)               1.60 (67.9--0)              0.002
   Difference (I--II)   0.46 (151.7--9.9)               1.33 (7.7--5.1)                0.5 (151.7--9.9)            0.637
  *P*-value             0.022                           0.576                                                      
  CA 19--9:                                                                                                        
   Preop = I            8.46 (161.5--0)                 10.415 (700--0)                8.46 (700--0)               0.977
   Postop = II          9.26 (44.5--0)                  12.08 (363--1.0)               9.84 (363.2--0)             0.131
   Difference (I--II)   0.43 (137.3--21.5)              --0.88 (7.2 -- --4.6)          0.24 (137.3--21.5)          0.667
  *P*-value             0.720                           0.805                          0.829                       

###### 

Survival analysis of the statistically significant parameters in the univariate analysis

  Variable                   Deceased *n* (%)   Surviving *n* (%)   Estimate survival Mean ± SE   Estimated proportion surviving at 5 years   *P*-value
  -------------------------- ------------------ ------------------- ----------------------------- ------------------------------------------- -----------
  Initial presentation:      0.028                                                                                                            
   Elective                  12 (16.7)          60 (83.3)           2.277.0 ±152.64               72.3                                        
   Emergency                 9 (36.0)           16 (64.0)           1.496.0 ±236.61               43.2                                        
  Lymphovascular invasion:   0.005                                                                                                            
   No                        9 (15.8)           48 (84.2)           2.052.9 ±128.83               73.1                                        
   Yes                       12 (37.5)          20 (62.5)           1.366.0 ±228.93               39.6                                        
  Age:                       0.001                                                                                                            
   ≤ 63                      4 (8.3)            44 (91.7)           2.577.7 ±142.46               86                                          
   \> 63                     17 (34.7)          32 (65.3)           1.496.6 ±171.34               43.1                                        
  Hb:                        0.005                                                                                                            
   \> 12.8                   1 (3.2)            30 (96.8)           2.756.0 ±119.80               93.3                                        
   ≤ 12.8                    17 (27.9)          44 (72.1)           1.666.4 ±156.03               58.2                                        
  N(+):                      0.001                                                                                                            
   ≤ 3                       12 (15.0)          68 (85.0)           2.342.5 ±139.83               74.6                                        
   \> 3                      7 (58.3)           5 (41.7)            1.049.7 ±276.31               19.3                                        
  N(+)/total N:              0.001                                                                                                            
   ≤ 0.0435                  7 (11.7)           53 (88.3)           2.159.4 ±114.74               79                                          
   \> 0.0435                 12 (37.5)          20 (62.5)           1.544.9 ±265.02               40.1                                        
  Thrombocytes:              0.010                                                                                                            
   ≤ 308                     5 (10.2)           44 (89.8)           2.185.9 ±126.07               82.6                                        
   \> 308                    13 (30.2)          30 (69.8)           1.856.0 ±225.20               57                                          
  Total                      21 (21.6)          76 (78.4)           2.120.9 ±140.08               64.6                                        

Kaplan-Meier test log rank (Mantel-Cox). SE -- standard error.

The two groups were compared for categorical variables using the Pearson χ^2^ and Fisher's exact tests. While there were significant differences between the two groups with respect to type of presentation (*p* = 0.036) and lymphovascular invasion (*p* = 0.028), other categorical variables did not show any significant difference. The patients who presented to the emergency department and subsequently underwent emergency surgery had a mortality rate of 40.7% while those who presented on an elective basis had a mortality rate of 18.9%. In other words, the mortality rate was 2.9 (95% CI: 1.1--7.7) times greater among patients who underwent emergency surgery compared to those who underwent elective surgery. An analysis of the lymphovascular invasion status revealed that the patients with lymphovascular invasion had a mortality rate of 41.2% and the rest of the patients had a mortality rate of 18.6%. In short, the mortality rate was 3.1 (95% CI: 1.1--7.9) times greater in patients with lymphovascular invasion compared to those without. Detailed information about categorical variables is provided in [Table I](#t0001){ref-type="table"}.

The two groups were compared for continuous variables using the independent t and Mann-Whitney U tests. Significant differences were found for age (*p* = 0.001), hemoglobin (*p* = 0.001), N(+) (*p* = 0.009), N(+)/total N (*p* = 0.012) and thrombocyte count (*p* = 0.047) between the two groups whereas other continuous variables did not show any significant difference. The details of these analyses are provided in [Table II](#t0002){ref-type="table"}. A ROC curve was drawn to determine the statistically significant cut-off points for the statistically significant variables in [Table II](#t0002){ref-type="table"}. The cut-off levels calculated for age (≤ 63 years vs. \> 63 years), hemoglobin (≤ 12.8 vs. \> 12.8), N(+) (≤ 3 vs. \> 3) and N(+)/total N (≤ 0.0435 vs. \> 0.0435) were statistically significant whereas the one calculated for thrombocyte count (≤ 308 vs. \> 308) was not statistically significant. That is, the mortality risk of those aged \> 63 years was 7.7 (95% CI: 2.1--28.8) times greater than that of those aged ≤ 63 years. The corresponding odds ratios for mortality calculated for hemoglobin, N(+) and N(+)/total N parameters were 13.9 (95% CI: 1.7--109.6), 7.1 (95% CI: 1.9--25.8), and 3.8 (95% CI: 1.4--10.7), respectively. The results of these analyses are shown in [Table III](#t0003){ref-type="table"}. The sensitivity and specificity values of the cut-off points calculated for age, hemoglobin, N(+) and N(+)/total N parameters are shown in [Figures 1](#f0001){ref-type="fig"}--[4](#f0004){ref-type="fig"}.
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The groups were also compared in terms of preoperative and postoperative serum CEA and CA 19-9 levels. Although there was no significant difference between the groups' preoperative CEA levels, the postoperative CEA levels significantly differed from each other (*p* = 0.002). In other words, a significant reduction occurred in the postoperative CEA levels compared to the preoperative CEA levels in the surviving group (*p* = 0.022) whereas the deceased group had an increased postoperative CEA level. The two groups did not show any significant difference in either preoperative or postoperative CA 19-9 levels. These analyses are shown in detail in [Table IV](#t0004){ref-type="table"}.

Kaplan-Meier log rank (Mantel-Cox) analysis was used to analyze the effects of the statistically significant categorical and continuous variables in the univariate analysis on survival ([Table V](#t0005){ref-type="table"}). A multivariate analysis revealed that initial presentation (*p* = 0.028), lymphovascular invasion (*p* = 0.005), age (*p* = 0.001), hemoglobin (*p* = 0.005), N(+) (*p* = 0.001), N(+)/total N (*p* = 0.001), and thrombocyte (*p* = 0.01) count were the significant independent predictors of mortality. The 5-year survival rate was also calculated, which was 72.3% among patients who underwent elective surgery and 43.2% among those who underwent emergency surgery. The 5-year survival rates for lymphovascular invasion (no/yes), age (≤ 63/\> 63), hemoglobin (\> 12.8/≤ 12.8), N(+) (≤ 3/\> 3), N(+)/total N (≤ 0.0435/\> 0.0435), and thrombocyte count (≤ 308/\> 308) were 73.1%/39.6%, 86%/43.1%, 93.3%/58.2%, 74.6%/19.3%, 79%/40.1%, and 82.6%/57%, respectively. The overall 5-year overall survival rate was 64.6%.

The predictors of mortality were also subjected to Cox regression backward stepwise analysis, the results of which are shown in [Table VI](#t0006){ref-type="table"}. Accordingly, age \> 63 years (*p* = 0.049), hemoglobin ≤ 12.8 (*p* = 0.045), and N(+)/total N ratio \> 0.0435 significantly and independently predicted mortality. In other words, age \> 63 years increased mortality by 3.55 (95% CI: 1.01--12.68) times, hemoglobin ≤ 12.8 by 7.99 times (95% CI: 1.05--61.01), and N(+)/total N ratio \> 0.0435 by 3.24 (95% CI: 1.16--9.03) times.

###### 

Analysis of the statistically significant parameters for survival using the Cox regression model

  Parameter                  B ± SE       *P*-value   Odds ratio (95% CI)
  -------------------------- ------------ ----------- ---------------------
  Age (\> 63)                1.27 ±0.65   0.049       3.55 (1.01--12.68)
  Hb (≤ 12.8)                2.08 ±1.04   0.045       7.99 (1.05--61.01)
  N(+)/total N (\> 0.0435)   1.18 ±0.52   0.025       3.24 (1.16--9.03)

Cox regression -- backward stepwise (Wald) method. B -- regression coefficients, SE -- standard error, CI -- confidence interval.

Discussion {#sec5}
==========

Although colorectal cancers affect every age group, their incidence increases in the fifth decade and rises further thereafter. Several studies have indicated that the current prevalence of colorectal cancers under the age of 50 has increased by at least 10% compared to the past \[[@cit0003]\]. This is partly a result of improved access to information technologies and advances in diagnostic medical tools. The youngest patient in our study group was 29 years old and the oldest was 87 years old. Although the disease prevalence is 1.3--2 times greater in men than in women, there exist some variations in gender-based prevalence of the disease in the literature \[[@cit0004], [@cit0005]\]. Our study population similarly had a male/female ratio of 1.4/1, and the gender difference between the alive and dead groups was non-significant. Several studies have identified age at diagnosis as an important prognostic factor whereas some others have reported the opposite \[[@cit0006]--[@cit0008]\]. Although some debate still exists, previous studies predominantly identified age (≥ 90 years), ASA score ≥ 3, undergoing combined surgery, low hemoglobin level (\< 10 g/dl) and low albumin level (\< 3.4 g/dl) as independent risk factors for postoperative 30-day mortality. The major prognostic factors for postoperative 1-year mortality include an ASA score ≥ 3, a TNM stage of IV, and the development of postoperative complications \[[@cit0006]--[@cit0008]\]. Our study identified age at diagnosis as an important prognostic factor. We found a significant 7.7-fold (95% CI: 2.1--28.8) increase in mortality risk among patients older than 63 years compared to those aged equal to or less than 63 years. This difference may have resulted from the challenges of cancer treatment and the poor general health status of colorectal cancer patients.

Patients with colorectal cancer usually initially present with rectal bleeding, constipation, obstructive complaints, abdominal pain, weight loss, loss of appetite, anemia, abdominal mass, metastasis-related complaints, and rarely atypical complaints. Our patients also had predominantly (88%) rectal bleeding, altered bowel habits (constipation, obstructive complaints of varying intensity), and abdominal pain. No significant difference existed between the alive and dead patient groups with respect to the admission complaints. However, the mortality rate of patients who presented to the emergency department and who subsequently underwent surgery was 2.9 (95% CI: 1.1--7.7) times greater than that of those who were operated on on an elective basis.

Several studies in the literature have shown that quantitative real-time reverse transcription-PCR (qRT-PCR) is an independent predictor for the detection of nodal micrometastases and circulating tumor cells in patients with colorectal cancer \[[@cit0009], [@cit0010]\]. It has also been shown that a high preoperative D-dimer level was associated with a worse prognosis than a low D-dimer level \[[@cit0011], [@cit0012]\]. We did not routinely study the preoperative D-dimer level or postoperative qRT-PCR. It was previously reported that a high preoperative neutrophil/lymphocyte ratio prior to chemoradiotherapy was an adverse prognostic sign (10). It was also found that a high preoperative platelet level was an independent risk factor for colorectal cancer mortality and metastasis \[[@cit0013]\]. Our study identified significant differences between hemoglobin level (*p* = 0.001) and thrombocyte count (*p* = 0.047) of the two groups but it failed to detect any significant difference for other continuous variables. That is, neutrophil/lymphocyte ratio had no prognostic significance but a high platelet count was associated with worse prognosis and more frequent recurrence. In contrast, a high hemoglobin level was a predictor of a significantly better prognosis (*p* = 0.045) (a hemoglobin level of ≤ 12.8 was associated with a 7.99 times higher mortality risk). Lymphovascular and perineural invasion is associated with mortality from colorectal cancers \[[@cit0014]\]. Similarly, lymphovascular invasion (*p* = 0.005) and a N(+)/total N ratio of greater than 0.0435 (*p* = 0.001) were significant predictors of mortality, as was indicated previously in the literature.

Regional lymph node metastasis is the most important prognostic factor in patients with colorectal cancer \[[@cit0010], [@cit0015]\]. While there is a theoretical risk for recurrence of 25% in patients who are cancer free (pN0) after surgery, this risk exceeds 50% in patients with metastases to 4 or more lymph nodes (pN2,3,4) \[[@cit0016], [@cit0017]\]. It has been reported that guanylyl cyclase C (GUCY2C) and qRT-PCR effectively showed occult metastases in patients with stage cancer pN0 \[[@cit0009], [@cit0010], [@cit0018]\]. The histopathological evaluation of patients receiving neoadjuvant radiotherapy showed that recurrences are more frequent in patients with a high tumor regression grade (TRG) \[[@cit0019]\]. Many randomized clinical studies have so far reported that adjuvant chemotherapy and close follow-up are useful to improve postoperative patient surveillance. The postoperative surveillance of patients undergoing colorectal surgery can be performed using abdomen/pelvis CT (CT A/P) or abdominal ultrasonography (AUS) to visualize the abdominopelvic region; X-ray (CXR) or CT of the chest to visualize the thoracic region; endoscopy in the form of flexible sigmoidoscopy or colonoscopy; or tumor markers such as CEA \[[@cit0020]--[@cit0022]\]. Although CEA is not specific for colorectal cancer, it is an important tumor marker with a sensitivity of 34--64% which is used for follow-up \[[@cit0022], [@cit0023]\]. However, it has been reported that colonoscopic surveillance and especially the CEA test are not routinely performed for follow-up in a majority of patients. Although our study also revealed a significant difference between the postoperative CEA values of the alive and dead groups (*p* = 0.002), CEA level was determined in only 60% (*n* = 60) of the patients.

One of the major findings of our study is that patients who presented to the emergency department and who were subsequently operated on for colorectal cancer have an increased risk of death, necessitating a more aggressive and careful treatment approach. Despite this, excess mortality resulting from independent risk factors can be reduced but not completely eliminated. Although colorectal cancers are associated with high overall mortality, higher success rates can be achieved in early stage cancer, which necessitates novel efforts to prevent cancer spread and to develop methods facilitating early diagnosis, which is the only way to reduce the mortality from these cancers.

Conclusions {#sec6}
===========

A univariate analysis revealed significant differences between the groups with respect to type of presentation, lymphovascular invasion, age, Hb, N(+), N(+)/total N, and thrombocyte levels. A ROC curve was used to determine the best cut-off points for the significant predictors of mortality in the univariate analysis. At the specified cut-off points, age (\> 63), Hb (≤ 12.8), N(+) (\> 3) and N(+)/total N (\> 0.435) levels were significantly associated with mortality. Kaplan-Meier test log rank (Mantel-Cox) analysis showed that the 5-year survival was worse in patients with emergency presentation, lymphovascular invasion, age \> 63, Hb ≤ 12.8, N \> 3, N(+)/total N \> 0.0435, and thrombocyte count \> 308 compared to other patients. A multivariate analysis using the Cox regression backward stepwise (Wald) method demonstrated that age (\> 63), Hb (≤ 12.8), and N(+)/total N (\> 0.0435) ratio were significant predictors of mortality. The retrospective design and the small sample volume prevents us from making robust suggestions for the predictors of colorectal cancer mortality. However, the robust systematics of the statistical analyses of this study and its statistically significant results make this study worth publishing.

Conflict of interest
====================

The authors declare no conflict of interest.
